BCS | BarclaysNYSEADR golden cross and death cross projections, cross tests and history

$22.40
-$0.21 (-0.93%)

Barclays (BCS) is a NYSE-listed ADR that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $22.40 vs 50 $24.37 / 200 $24.83
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross 26 Oct 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $22.30 vs 50 $24.72 / 200 $15.07
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 8 Jul 2024 ยท projected 27 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $22.49 vs 50 $22.88 / 200 $25.89
Projection
No cross projected
Test
No active test
Last cross
Death cross 25 Sep 2026 ยท projected 26 bars out

Cross history

25
crosses on record since 2017
12 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
26 Oct 2026Death steepdaily30 bars outActive Cross Test
25 Sep 2026Death4-hour26 bars outNot tested
9 Jun 2026Golden4-hour27 bars out3 bar cross test
28 May 2026Golden moderatedaily17 bars outNot tested
7 May 2026Death moderatedaily14 bars out3 bar cross test

About BCS

ExchangeNYSE
InstrumentADR
Median $ volume, 60 d$109M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.